90 results
424B3
RGBP
Regen BioPharma Inc
10 May 24
Prospectus supplement
3:50pm
or practices, financial statement disclosures, or auditing scope or procedure, which disagreements, if not resolved to BF Borger’s satisfaction, would
8-K
RGBP
Regen BioPharma Inc
10 May 24
Changes in Registrant's Certifying Accountant
3:49pm
, or auditing scope or procedure, which disagreements, if not resolved to BF Borger's satisfaction, would have caused BF Borger to make reference to the subject
424B3
RGBP
Regen BioPharma Inc
24 Apr 24
Prospectus supplement
1:28pm
Fees are recognized upon satisfaction of all conditions required to be satisfied in order for that revenue to have been earned by the Company.
M … , 2018 the Company accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued
424B3
RGBP
Regen BioPharma Inc
19 Jan 24
Prospectus supplement
1:29pm
satisfaction of all conditions required to be satisfied in order for that revenue to have been earned by the Company.
M. INTEREST RECEIVABLE … accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued interest owed
424B3
8il3bdtmzaa svk
20 Nov 23
Prospectus supplement
9:38am
424B3
vv655nb6izr9a3s
2 Oct 23
Prospectus supplement
1:42pm
8-K
EX-10.1
5n0ma z1j90
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.3
54a9e 7hmtvo
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.2
kkuk0r21
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
424B3
eria1rls
15 May 23
Prospectus supplement
10:25am